Cervical cancer vaccination

The vaccine protects against precancer (CIN) and cancer of the cervix (neck of the womb) due to Human Papilloma Virus (HPV) types 16 and 18. These account for 70% of such cases in the UK.

The vaccine is highly effective.

The vaccine is not useful for treatment of precancer and cancer of the cervix but can prevent reinfection after treatment.

The vaccine also protects against HPV types 6 and 11 which cause visible genital warts.

The vaccine is licensed for women and girls between the ages of 9 and 26. Vaccination beyond the age of 26 is at the discretion of the doctor.

Do not have a cervical cancer vaccination if you think you might be pregnant or have an infection with a high temperature.

Injections are usually given into the upper arm muscle and it is normal to have some soreness at the injection site for a few days. You may have a slightly raised temperature as well. Intramuscular injections can cause bruising if you have a bleeding tendancy.